Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)—a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma

Key Points

Key points are not available for this paper at this time.

Abstract

This study illustrates the potential of ctDNA as a biomarker for detecting minimal residual disease and recurrence in HNSCC and demonstrates the feasibility of personalised ctDNA assays for the detection of disease prior to clinical recurrence.

Bookmark

View Full Paper

Cite This Study

Flach et al. (Mon,) studied this question.

synapsesocial.com/papers/69dea71e6bae133e7de947b6 https://doi.org/https://doi.org/10.1038/s41416-022-01716-7

Bookmark

View Full Paper